Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126698661 | 12669866 | 1 | I | 20120129 | 20120216 | 20160819 | 20160819 | EXP | US-VALIDUS PHARMACEUTICALS LLC-US-2012VAL000701 | VALIDUS | 0.00 | Y | 0.00000 | 20160819 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126698661 | 12669866 | 1 | PS | CALCITRIOL. | CALCITRIOL | 1 | Oral | 1 ?G, QD | U | 18044 | 1 | UG | |||||||
| 126698661 | 12669866 | 2 | C | GENTAMYCIN /00047101/ | GENTAMICIN | 1 | UNK | U | 0 | ||||||||||
| 126698661 | 12669866 | 3 | C | SODIUM CHLORIDE. | SODIUM CHLORIDE | 1 | 4 MEQ, TID | U | 0 | 4 | MEQ | ||||||||
| 126698661 | 12669866 | 4 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 50 ?G, QD | U | 0 | 50 | UG | |||||||
| 126698661 | 12669866 | 5 | C | REGLAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Oral | 5MG/5ML, TID | U | 0 | |||||||||
| 126698661 | 12669866 | 6 | C | PREVACID | LANSOPRAZOLE | 1 | Oral | 7.5 MG, QD | U | 0 | 7.5 | MG | BUCCAL TABLET | ||||||
| 126698661 | 12669866 | 7 | C | EPOETIN ALFA | ERYTHROPOIETIN | 1 | 2000 IU, 3 IN 1 WEEK | U | 0 | 2000 | IU | CUTANEOUS SPONGE | |||||||
| 126698661 | 12669866 | 8 | C | CALCIUM CARBONATE. | CALCIUM CARBONATE | 1 | UNK | U | 0 | ||||||||||
| 126698661 | 12669866 | 9 | C | KAYEXALATE | SODIUM POLYSTYRENE SULFONATE | 1 | UNK | U | 0 | ||||||||||
| 126698661 | 12669866 | 10 | C | QVAR | BECLOMETHASONE DIPROPIONATE | 1 | 40 ?G, BID | U | 0 | 40 | UG | ||||||||
| 126698661 | 12669866 | 11 | C | ALBUTEROL /00139501/ | ALBUTEROL | 1 | 0.083 %, QID | U | 0 | .083 | PCT | CUTANEOUS SUSPENSION | |||||||
| 126698661 | 12669866 | 12 | C | CEFAZOLIN | CEFAZOLIN | 1 | UNK | U | 0 | DENTAL GEL | |||||||||
| 126698661 | 12669866 | 13 | C | FORTAZ | CEFTAZIDIME SODIUM | 1 | UNK | U | 0 | ||||||||||
| 126698661 | 12669866 | 14 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 126698661 | 12669866 | 15 | C | FLAGYL | METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 126698661 | 12669866 | 16 | C | AMPHOTERICIN | AMPHOTERICIN B | 1 | UNK | U | 0 | ||||||||||
| 126698661 | 12669866 | 17 | C | NYSTATIN. | NYSTATIN | 1 | 100000 UNITS/ML | U | 0 | ||||||||||
| 126698661 | 12669866 | 18 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | 5MG/5ML | U | 0 | ||||||||||
| 126698661 | 12669866 | 19 | C | FERROUS /00023501/ | 2 | 15MG/ML | U | 0 | |||||||||||
| 126698661 | 12669866 | 20 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 2 ML, QD | U | 0 | 2 | ML | CONCENTRATE FOR GARGLE | |||||||
| 126698661 | 12669866 | 21 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | Oral | 15MG/ML, BID | U | 0 | |||||||||
| 126698661 | 12669866 | 22 | C | DOPAMINE | DOPAMINEDOPAMINE HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 126698661 | 12669866 | 23 | C | HEPARIN | HEPARIN SODIUM | 1 | 500 IU, UNK | U | 0 | 500 | IU | ||||||||
| 126698661 | 12669866 | 24 | C | VANCOMYCIN | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126698661 | 12669866 | 1 | Product used for unknown indication |
| 126698661 | 12669866 | 2 | Product used for unknown indication |
| 126698661 | 12669866 | 3 | Product used for unknown indication |
| 126698661 | 12669866 | 4 | Product used for unknown indication |
| 126698661 | 12669866 | 5 | Product used for unknown indication |
| 126698661 | 12669866 | 6 | Product used for unknown indication |
| 126698661 | 12669866 | 7 | Product used for unknown indication |
| 126698661 | 12669866 | 8 | Product used for unknown indication |
| 126698661 | 12669866 | 9 | Product used for unknown indication |
| 126698661 | 12669866 | 10 | Product used for unknown indication |
| 126698661 | 12669866 | 11 | Product used for unknown indication |
| 126698661 | 12669866 | 12 | Product used for unknown indication |
| 126698661 | 12669866 | 13 | Product used for unknown indication |
| 126698661 | 12669866 | 14 | Product used for unknown indication |
| 126698661 | 12669866 | 15 | Product used for unknown indication |
| 126698661 | 12669866 | 16 | Product used for unknown indication |
| 126698661 | 12669866 | 17 | Product used for unknown indication |
| 126698661 | 12669866 | 18 | Product used for unknown indication |
| 126698661 | 12669866 | 19 | Product used for unknown indication |
| 126698661 | 12669866 | 20 | Product used for unknown indication |
| 126698661 | 12669866 | 21 | Product used for unknown indication |
| 126698661 | 12669866 | 22 | Product used for unknown indication |
| 126698661 | 12669866 | 23 | Product used for unknown indication |
| 126698661 | 12669866 | 24 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126698661 | 12669866 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126698661 | 12669866 | Abdominal distension | |
| 126698661 | 12669866 | Fluid overload | |
| 126698661 | 12669866 | Nasal congestion | |
| 126698661 | 12669866 | Pyrexia | |
| 126698661 | 12669866 | Rhinorrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |